18.7 C
New York
Saturday, June 3, 2023

Momentum Is Strong For X4 Pharmaceuticals Inc. (NASDAQ: XFOR)

After Hours

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. After-hours trades for X4 Pharmaceuticals Inc. (XFOR) shows that investor sentiment remained same, with the stock’s consolidated last price remained same to $1.61. The X4 Pharmaceuticals Inc. has recorded 17,694 volume in the after hours trading session. Earlier, Yahoo Finance discussed this stock as it revealed X4 Pharmaceuticals Reports First-Quarter 2023 Financial Results and Provides Corporate Update.

Unlock the Hottest Top 10 Penny Stocks Today! Discover Now

Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.

Gain Access to Top 10 Penny Stocks Now!.


Stocks Info

This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. At the end of the last regular session, the stock closed at $1.61 and fluctuated between $1.6300 as its day high and $1.5200 as its day low. The current market capitalization of X4 Pharmaceuticals Inc. is $178.24M. A total of 2.58 million shares were traded on the day, compared to an average of 1.87M shares.

In the most recent transaction, Mostafa Adam S. sold 52,500 shares of XFOR for 0.84 per share on Mar 10. After the transaction, the Chief Financial Officer now owns 93,696 company shares. In a previous transaction on Mar 10, Ragan Paula sold 49,678 shares at 0.84 per share. XFOR shares that President and CEO owns now total 563,537.

Among the insiders who sold shares, DiBiase Mary disposed of 18,192 shares on Mar 10 at a per-share price of $0.84. This resulted in the Chief Operating Officer holding 152,714 shares of XFOR after the transaction. In another insider transaction, Taveras Arthur sold 16,806 shares at $0.84 per share on Mar 10. Company shares held by the Chief Scientific Officer now total 86,373.

Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. According to analysts who have offered 12-month price targets for XFOR in the last 3 months, the mean price target is $3.50 with high estimates of $4.50 and low estimates of $3.00. In terms of 52-week highs and lows, XFOR has a high of $2.41 and a low of $0.65.

As of this writing, XFOR has an earnings estimate of -$0.18 per share for the current quarter. EPS was calculated based on a consensus of 8 estimates, with a high estimate of -$0.15 per share and a lower estimate of -$0.22. The company reported an EPS of -$0.29 in the last quarter, which was -20.80% lower than expectations of -$0.24.

Balance Sheet Annually/Quarterly

In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. XFOR’s latest balance sheet shows that the firm has $81.79M in Cash & Short Term Investments as of fiscal 2021. There were $39.78M in debt and $14.02M in liabilities at the time. Its Book Value Per Share was $0.35, while its Total Shareholder’s Equity was $64.41M.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for XFOR is Buy with a score of 5.00.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles